Pre-Diabetes/Borderline Diabetes (Pre-cursor to Diabetes Mellitus)

Prediabetes, also commonly referred to as borderline diabetes, is a metabolic condition and growing global problem that is closely tied to obesity. Prediabetes is the precursor stage before diabetes mellitus in which not all of the symptoms required to diagnose diabetes are present, but blood sugar is abnormally high. Prediabetes is characterized by the presence of blood glucose levels that are higher than normal but not yet high enough to be classed as diabetes.
For this reason, prediabetes is often described as the “gray area” between normal blood sugar and diabetic levels. In the UK, around 7 million people are estimated to have prediabetes and thus have a high risk for developing type 2 diabetes. Prediabetes is associated with obesity (especially abdominal or visceral obesity), dyslipidemia with high triglycerides and/or low HDL cholesterol, and hypertension. It is thus a metabolic diathesis or syndrome, and it usually involves no symptoms and only high blood sugar as the sole sign.
The progression to type 2 diabetes mellitus is not inevitable for those with prediabetes. The progression into diabetes mellitus from prediabetes is approximately 25% over three to five years. For patients with severe risk factors, prescription medication may be appropriate. This may be considered in patients for whom lifestyle therapy has failed, or is not sustainable, and who are at high-risk for developing type 2 diabetes. Metformin and acarbose help prevent the development of frank diabetes, and also have a good safety profile. The most serious consequence of prediabetes is progression to type 2 diabetes.
 

  • Impaired fasting glycaemia
  • Impaired glucose tolerance
  • Insulin resistance
  • Tests for Pre-Diabetes
  • Cardiovascular diseases
  • Genetic Influence on Pre-diabetes
  • Healthy Meals and Physical Exercise
  • Type 2 Diabetes
  • GFR Estimation To Stop Kidney Disease
  • Erectile dysfunction and Nocturia

Related Conference of Pre-Diabetes/Borderline Diabetes (Pre-cursor to Diabetes Mellitus)

August 22-23, 2022

Global Meeting on Diabetes and Nursing Care

Prague, Czech Republic
August 22-23, 2022

Global Summit on Endocrinology

Budapest, Hungary
August 22-23, 2022

European Endocrinology and Diabetes Congress

Budapest, Hungary
August 29-30, 2022

Annual Congress on Endocrinology & Disorders

Berlin, Germany
September 19-20, 2022

4th International Conference on Cell Metabolism

Amsterdam, Netherlands
September 19-20, 2022

18th International Conference on Diabetes & Care

Amsterdam, Netherlands
September 22-23, 2022

3rd World Summit on Diabetes

Rome, Italy
September 23-24, 2022

World Congress on Endocrine and Diabetes

Rome, Italy
September 26-27, 2022

6th Annual Conference on Diabetes and Endocrinology

Amsterdam, Netherlands
September 27-28, 2022

2nd Annual Summit on Diabetes and Endocrinology

Rome, Italy
September 28-29, 2022

16th European Diabetes and Endocrinology Congress

Rome, Italy
October 14-15, 2022

2nd Global congress on Endocrinology and Gynecology

Sydney, Australia
November 09-10, 2022

31st International Diabetes and Healthcare Conference

Madrid, Spain
November 09-10, 2022

2nd International Congress and Expo on Diabetic Care

Bangkok, Thailand
November 16-17, 2022

World congress and Expo on Diabetes

Manila, Philippines
November 22-23, 2022

18th World Congress on Endocrinology & Diabetes

Amsterdam, Netherlands
November 28-29, 2022

International Conference on Diabetes & Heart Diseases

Yokohama, Japan
November 28-29, 2022

14th World Congress on Endocrinology and Metabolic Disorders

Sydney, Australia
January 30-31, 2023

6th Annual Meeting on Diabetes and Endocrinology

Barcelona, Spain
February 22-23, 2023

32nd European Diabetes Congress

Madrid,
May 15-16, 2023

4th Global summit on Diabetes and Endocrinology

Madrid, Spain

Pre-Diabetes/Borderline Diabetes (Pre-cursor to Diabetes Mellitus) Conference Speakers

Recommended Sessions

Related Journals

Are you interested in